Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy
This prospective observational study aims to evaluate the prognostic significance of early postoperative prostate-specific antigen (PSA) levels in patients undergoing radical prostatectomy for prostate cancer. No investigational interventions will be performed. All diagnostic procedures, follow-up assessments, and treatments will be conducted in accordance with standard clinical practice and established prostate cancer management guidelines. Participation in the study will not influence treatment decisions.
• Patient is an adult biological male.
• Patient has morphologically confirmed and untreated prostate cancer.
• Patient who will be treated with open, laparoscopic or robot-assisted laparoscopic radical prostatectomy.
• Patient is informed about this observational study and has signed the informed consent form.